• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

JJ Surgical Vision Dying or Not?





The WORST lead ophthalmology company or NOT??
Come on......let them have it!
Of course they are....all J&J does is check boxes for employee's. Take for instance the USELESS, two or maybe even 3 boxes checked for the BUG EYED gal at JJSV in the South. Absolutely USELESS and had ZERO experience in ophthalmology. J&J lost all of its talent in the layoffs of 2019 and especially the 1/5/20 layoffs with 35 person's with Sx ophthalmology sales of some 900+ years. All that talent is GONE TO OTHER COMPANIES!!! Right RXSIGHT.......haaaaaa. Warren is a JACKWAGON. Just a coolaid drinkin CREDO diplomate.